Zymeworks revenue breakdown by business segment: 100.0% from CLINICAL-STAGE BIOPHARMACEUTICAL
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Revenue | 53.0m | 29.5m | 39.0m | 26.7m |
Gross profit | 53.0m | 29.5m | 39.0m | 26.7m |
R&D expense | (56.9m) | (115.9m) | (168.5m) | (199.8m) |
Operating expense total | (82.8m) | (174.7m) | (216.1m) | (232.7m) |
Depreciation and amortization | (3.6m) | (5.4m) | (10.3m) | (9.6m) |
EBITDA | (29.7m) | (145.1m) | (177.2m) | (206.0m) |
EBIT | (37.1m) | (150.7m) | (187.5m) | (215.5m) |
Interest income | 2.6m | 6.0m | 5.7m | 2.0m |
Pre tax profit | (34.4m) | (146.0m) | (180.1m) | (212.4m) |
Income tax expense | (2.2m) | 582.0k | (429.0k) | 516.0k |
Net Income | (36.6m) | (145.4m) | (180.6m) | (211.8m) |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 11.9m | 7.9m | 7.9m | 8.3m | 12.4m | 2.6m | 644.0k | 1.8m | 4.4m |
Gross profit | 11.9m | 7.9m | 7.9m | 8.3m | 12.4m | 2.6m | 836.0k | 1.7m | 4.4m |
R&D expense | (17.5m) | (23.8m) | (29.3m) | (36.5m) | (39.2m) | (53.5m) | (44.3m) | (50.7m) | (49.9m) |
Operating expense total | (25.0m) | (35.0m) | (39.7m) | (41.3m) | (50.4m) | (73.7m) | (43.0m) | (67.9m) | (62.6m) |
Depreciation and amortization | (1.5m) | (1.6m) | (1.7m) | (2.8m) | (2.3m) | (2.7m) | (2.6m) | (2.8m) | (2.8m) |
EBITDA | (13.1m) | (27.1m) | (31.9m) | (33.0m) | (38.1m) | (71.0m) | (42.1m) | (66.2m) | (58.2m) |
EBIT | (14.6m) | (28.7m) | (33.6m) | (35.9m) | (40.3m) | (73.7m) | (44.7m) | (69.0m) | (61.0m) |
Interest expense | (18.0k) | (52.0k) | (20.0k) | (38.0k) | |||||
Interest income | 1.3m | 1.2m | 2.1m | 1.9m | 1.5m | 1.3m | 741.0k | 588.0k | 340.0k |
Pre tax profit | (13.4m) | (28.4m) | (31.4m) | (30.8m) | (39.0m) | (72.6m) | (44.1m) | (68.0m) | (59.8m) |
Income tax expense | (193.0k) | (635.0k) | 908.0k | (375.0k) | 64.0k | 43.0k | (525.0k) | 434.0k | (764.0k) |
Net Income | (13.6m) | (29.1m) | (30.5m) | (31.1m) | (39.0m) | (72.6m) | (44.6m) | (67.5m) | (60.6m) |
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Cash | 42.2m | 128.5m | 242.0m | 201.9m |
Accounts Receivable | 358.0k | 2.2m | 15.3m | 15.6m |
Prepaid Expenses | 3.8m | 10.7m | 13.4m | 20.0m |
Current Assets | 204.4m | 311.8m | 455.1m | 288.2m |
PP&E | 6.5m | 11.1m | 12.2m | 22.8m |
Goodwill | 12.0m | 12.0m | 12.0m | 12.0m |
Total Assets | 244.5m | 368.2m | 538.4m | 389.1m |
Accounts Payable | 2.6m | 5.3m | 6.2m | 5.2m |
Short-term debt | 1.3m | 2.7m | 1.3m | |
Current Liabilities | 30.0m | 82.6m | 85.7m | 71.9m |
Long-term debt | 239.0k | 5.6m | 5.9m | 31.0m |
Non-Current Liabilities | 34.0m | 40.0m | 42.8m | 68.2m |
Total Debt | 239.0k | 6.9m | 8.6m | 32.3m |
Total Liabilities | 64.0m | 122.5m | 128.5m | 140.0m |
Common Stock | 320.1m | 450.2m | 724.2m | 741.1m |
Additional Paid-in Capital | 12.3m | 92.8m | 163.6m | 197.7m |
Retained Earnings | (145.3m) | (290.7m) | (471.3m) | (683.1m) |
Total Equity | 180.5m | 245.7m | 409.9m | 249.1m |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Cash | 43.2m | 283.5m | 250.8m | 189.5m | 219.6m | 244.1m | 279.9m | 257.2m | 253.4m |
Accounts Receivable | 703.0k | 2.7m | 3.3m | 8.7m | 14.8m | 3.7m | 4.6m | 9.2m | 4.9m |
Prepaid Expenses | 9.0m | 8.0m | 6.8m | 8.3m | 19.7m | 11.8m | 16.7m | 24.0m | 24.1m |
Current Assets | 190.3m | 366.4m | 345.3m | 504.6m | 471.3m | 487.3m | 432.8m | 393.0m | 336.8m |
PP&E | 13.9m | 15.7m | 15.6m | 11.0m | 12.5m | 12.5m | 12.3m | 14.0m | 18.6m |
Goodwill | 12.0m | 12.0m | 12.0m | 12.0m | 12.0m | 12.0m | 12.0m | 12.0m | 12.0m |
Total Assets | 238.3m | 414.5m | 400.0m | 636.6m | 606.9m | 571.7m | 490.1m | 472.0m | 420.4m |
Accounts Payable | 1.4m | 4.1m | 8.0m | 12.5m | 4.7m | 3.1m | 4.9m | 4.7m | 5.0m |
Short-term debt | 1.7m | 1.7m | 921.0k | 1.7m | 1.9m | 1.9m | 3.0m | 1.6m | 1.3m |
Current Liabilities | 28.2m | 40.4m | 50.7m | 72.9m | 72.8m | 96.9m | 70.2m | 83.0m | 75.4m |
Long-term debt | 6.4m | 6.2m | 5.9m | 7.3m | 6.7m | 6.0m | 5.4m | 30.2m | 28.7m |
Non-Current Liabilities | 40.1m | 40.1m | 39.8m | 41.3m | 42.8m | 42.5m | 42.7m | 67.5m | 66.0m |
Total Debt | 8.1m | 7.9m | 6.8m | 9.1m | 8.6m | 7.9m | 8.4m | 31.8m | 30.1m |
Total Liabilities | 68.3m | 80.5m | 90.5m | 114.2m | 115.6m | 139.4m | 112.9m | 150.5m | 141.4m |
Common Stock | 320.9m | 441.2m | 444.4m | 707.6m | 708.3m | 715.3m | 729.0m | 730.3m | 739.6m |
Additional Paid-in Capital | 14.6m | 87.5m | 90.2m | 143.3m | 150.4m | 157.1m | 170.6m | 181.2m | 190.0m |
Retained Earnings | (158.9m) | (188.0m) | (218.5m) | (321.8m) | (360.8m) | (433.4m) | (515.9m) | (583.4m) | (644.0m) |
Total Equity | 170.0m | 334.0m | 309.5m | 522.4m | 491.3m | 432.4m | 377.1m | 321.5m | 278.9m |
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Net Income | (36.6m) | (145.4m) | (180.6m) | (211.8m) |
Depreciation and Amortization | 3.6m | 5.4m | 7.5m | 6.5m |
Accounts Receivable | (119.0k) | (1.8m) | (13.1m) | (266.0k) |
Accounts Payable | 3.7m | 21.6m | 7.6m | 16.5m |
Cash From Operating Activities | 24.2m | (81.9m) | (151.4m) | (192.5m) |
Cash From Investing Activities | (109.0m) | (25.6m) | (43.4m) | 144.6m |
Long-term Borrowings | (11.0k) | (16.0k) | ||
Cash From Financing Activities | 91.4m | 193.7m | 309.0m | 8.0m |
Net Change in Cash | 6.3m | 86.2m | 113.6m | (40.2m) |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (13.6m) | (42.7m) | (73.2m) | (31.1m) | (70.1m) | (142.7m) | (44.6m) | (112.1m) | (172.7m) |
Depreciation and Amortization | 1.5m | 3.1m | 4.7m | 1.8m | 3.5m | 5.5m | 2.0m | 4.1m | 5.5m |
Accounts Receivable | 320.0k | (1.4m) | (2.1m) | (6.5m) | (12.6m) | (1.5m) | 10.7m | 6.1m | 10.4m |
Accounts Payable | (2.4m) | 2.8m | 12.4m | 1.1m | (1.8m) | 15.1m | (163.0k) | 10.3m | 10.7m |
Cash From Operating Activities | (21.3m) | (34.6m) | (45.5m) | (37.5m) | (87.4m) | (103.5m) | (40.8m) | (91.2m) | (141.9m) |
Cash From Investing Activities | 22.0m | 85.4m | 62.6m | (204.8m) | (124.4m) | (86.8m) | 76.8m | 104.1m | 146.5m |
Long-term Borrowings | (8.0k) | (11.0k) | (13.0k) | ||||||
Cash From Financing Activities | 569.0k | 190.5m | 191.5m | 302.8m | 303.0m | 306.3m | 2.1m | 2.8m | 7.3m |
Net Change in Cash | 969.0k | 241.3m | 208.6m | 61.0m | 91.1m | 115.7m | 37.9m | 15.1m | 11.4m |
USD | FY, 2018 |
---|